Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Depreciation and Depletion (2024 - 2025)

Maxcyte (MXCT) has disclosed Depreciation and Depletion for 2 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion changed 0.19% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at $4.3 million for FY2025, 0.65% down from the prior year.
  • Depreciation and Depletion for Q4 2025 was $1.1 million at Maxcyte, roughly flat from $1.1 million in the prior quarter.
  • The five-year high for Depreciation and Depletion was $1.1 million in Q2 2025, with the low at $1.1 million in Q4 2025.